Source: VAERS.HHS.GOV
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
within 2 days of the vaccine he began to feel dizzy, this progressed. he was admitted to hospital 2/1 and was found to have lacunar infarct as well as chronic cholecystitis as well as hypereosinophilia with AEC 4500-11000. no rash or renal failure. he had transamintiis that resolved with treatment of cholecystitis (percutaneous cholecystectomy). eosinophilia work up not yet completed at the time of this report.
Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)
| Name | Dose # | Type | Manufacturer | Lot | Route | Site |
|---|---|---|---|---|---|---|
| COVID19 (COVID19 (PFIZER-BIONTECH)) | 1 | COVID19 | PFIZER\BIONTECH | EJ1686 | IM | LA |
| COVID19 (COVID19 (PFIZER-BIONTECH)) | 2 | COVID19 | PFIZER\BIONTECH | EL3302 | IM | LA |
| RECVDATE: | 02-10-2021 | RPT_DATE: |
| CAGE_YR: | 80 |
| CAGE_MO: | |
| DIED: | U |
| DATEDIED: | |
| L_THREAT: | U |
| ER_VISIT: | |
| HOSPITAL: | Y |
| HOSPDAYS: | 10 |
| X_STAY: | U |
| DISABLE: | U |
| RECOVD: | N |
| LAB_DATA: | MRI brain 2/1: 1. There is a tiny acute periependymal lacunar infarct adjacent to the right lateral ventricle measuring 6 x 6 mm in AP and TV dimensions. 2. No other acute intracranial abnormality such as mass, midline shift, or hemorrhage. 3. Mild for age scattered white matter disease. ct cap 2/3 1. Cholelithiasis with gallbladder wall thickening and fat stranding in the porta hepatis, suspicious for acute cholecystitis. Small amount of ascites. 2. Diverticulosis. % Segmented Neutrophils % 34 % Lymphocytes % 12 % Monocytes % 4 % Eosinophils % 49 % Basophils % 1 % Immature Granulocytes 0.0 - 0.0 % TNP Absolute Segmented Neutrophils 1.40 - 7.00 th/mm3 7.65High Absolute Lymphocytes 0.70 - 3.10 th/mm3 2.70 Absolute Monocytes 0.10 - 0.90 th/mm3 0.90 Absolute Eosinophils 0.00 - 0.40 th/mm3 11.03High Absolute Basophils 0.00 - 0.20 th/mm3 0.22High |
| V_ADMINBY: | |
| OTHER_MEDS: | albuterol, aspirin, vit d3, Cymbalta, Flonase, Flovent, Advair, Neurontin, Claritin, vit e, |
| CUR_ILL: | Sjogrens syndrome (HCC); S Anemia, unspecified; ; Esophageal reflux; Unspecified asthma(493.90); Unspecified sleep apnea; Depressive disorder, |
| HISTORY: | LTBI, prostate cancer s/p prostatectomy, polyneuropathy, osteoporosis, |
| PRIOR_VAX: | |
| SPLTTYPE: | |
| FORM_VERS: | |
| TODAYS_DATE: | 02-10-2021 |
| BIRTH_DEFECT: | U |
| OFC_VISIT: | U |
| ER_ED_VISIT: | U |
| ALLERGIES: | levaquin |
| V_FUNDBY: |
Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.
AND PLEASE read the FAQ first.
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.